|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 417/14 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2331537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09782777.8 |
| Date of filing the European patent application | 2009-09-08 | |
| (97) | Date of publication of the European application | 2011-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
| (46) | Date of publication of the claims translation | 2016-01-25 |
| (86) | Number | PCT/EP2009/061644 |
| Date | 2009-09-08 |
| (87) | Number | WO 2010/029082 |
| Date | 2010-03-18 |
| (30) | Number | Date | Country code |
| 08164104 | 2008-09-10 | EP | |
| 96674 P | 2008-09-12 | US |
| (72) |
CARAVATTI, Giorgio, CH
FAIRHURST, Robin Alec, GB
FURET, Pascal, CH
GUAGNANO, Vito, CH
IMBACH, Patricia, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 1-((5-heteroariltiazol-2-il)aminokarbonil)pirolidin-2-karboksamido dariniai, kaip fosfatidilinozitolio 3-kinazės (PI3K) inhibitoriai, naudingi proliferacinių ligų gydyme |
| 1-((5-HETEROARYLTHIAZOL-2-YL)AMINOCARBONYL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITORS USEFUL IN THE TREATMENT OF PROLIFERATIVE DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 17 | 347.00 EUR |
| 2026-09-08 |